The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Cold and Cough Medicines Market Research Report 2025
Synopsis
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. The drugs for the treatment of cold and cough acts on the receptors to which the virus causing the infection gets attached to, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. Cold weather is not directly associated with common cold, but the virus which causes common cold, called rhinovirus, is responsible for all cold related illnesses. Once the virus is inhaled, it attaches to the cells in nasal passages.
The global OTC Cold and Cough Medicines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Cold and Cough Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Cold and Cough Medicines.
Report Scope
The OTC Cold and Cough Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Cold and Cough Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Cold and Cough Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi-Aventis
Johnson & Johnson
Reckitt Benckiser Group Plc.
Novartis AG
GlaxoSmithKline Plc.
AstraZeneca Plc.
Pfizer Inc.
Sun Pharmaceutical
Prestige Brands Holdings, Inc.
Procter & Gamble Co.
Segment by Type
Pellets
Drops
Tablets
Capsules
Powders
Sprays
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Cold and Cough Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Cold and Cough Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. The drugs for the treatment of cold and cough acts on the receptors to which the virus causing the infection gets attached to, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. Cold weather is not directly associated with common cold, but the virus which causes common cold, called rhinovirus, is responsible for all cold related illnesses. Once the virus is inhaled, it attaches to the cells in nasal passages.
The global OTC Cold and Cough Medicines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Cold and Cough Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Cold and Cough Medicines.
Report Scope
The OTC Cold and Cough Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Cold and Cough Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Cold and Cough Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi-Aventis
Johnson & Johnson
Reckitt Benckiser Group Plc.
Novartis AG
GlaxoSmithKline Plc.
AstraZeneca Plc.
Pfizer Inc.
Sun Pharmaceutical
Prestige Brands Holdings, Inc.
Procter & Gamble Co.
Segment by Type
Pellets
Drops
Tablets
Capsules
Powders
Sprays
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Cold and Cough Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Cold and Cough Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 OTC Cold and Cough Medicines Market Overview
1.1 Product Overview and Scope of OTC Cold and Cough Medicines
1.2 OTC Cold and Cough Medicines Segment by Type
1.2.1 Global OTC Cold and Cough Medicines Market Value Comparison by Type (2024-2030)
1.2.2 Pellets
1.2.3 Drops
1.2.4 Tablets
1.2.5 Capsules
1.2.6 Powders
1.2.7 Sprays
1.3 OTC Cold and Cough Medicines Segment by Application
1.3.1 Global OTC Cold and Cough Medicines Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global OTC Cold and Cough Medicines Market Size Estimates and Forecasts
1.4.1 Global OTC Cold and Cough Medicines Revenue 2019-2030
1.4.2 Global OTC Cold and Cough Medicines Sales 2019-2030
1.4.3 Global OTC Cold and Cough Medicines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 OTC Cold and Cough Medicines Market Competition by Manufacturers
2.1 Global OTC Cold and Cough Medicines Sales Market Share by Manufacturers (2019-2024)
2.2 Global OTC Cold and Cough Medicines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global OTC Cold and Cough Medicines Average Price by Manufacturers (2019-2024)
2.4 Global OTC Cold and Cough Medicines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Cold and Cough Medicines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Cold and Cough Medicines, Product Type & Application
2.7 OTC Cold and Cough Medicines Market Competitive Situation and Trends
2.7.1 OTC Cold and Cough Medicines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OTC Cold and Cough Medicines Players Market Share by Revenue
2.7.3 Global OTC Cold and Cough Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OTC Cold and Cough Medicines Retrospective Market Scenario by Region
3.1 Global OTC Cold and Cough Medicines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global OTC Cold and Cough Medicines Global OTC Cold and Cough Medicines Sales by Region: 2019-2030
3.2.1 Global OTC Cold and Cough Medicines Sales by Region: 2019-2024
3.2.2 Global OTC Cold and Cough Medicines Sales by Region: 2025-2030
3.3 Global OTC Cold and Cough Medicines Global OTC Cold and Cough Medicines Revenue by Region: 2019-2030
3.3.1 Global OTC Cold and Cough Medicines Revenue by Region: 2019-2024
3.3.2 Global OTC Cold and Cough Medicines Revenue by Region: 2025-2030
3.4 North America OTC Cold and Cough Medicines Market Facts & Figures by Country
3.4.1 North America OTC Cold and Cough Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America OTC Cold and Cough Medicines Sales by Country (2019-2030)
3.4.3 North America OTC Cold and Cough Medicines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Cold and Cough Medicines Market Facts & Figures by Country
3.5.1 Europe OTC Cold and Cough Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe OTC Cold and Cough Medicines Sales by Country (2019-2030)
3.5.3 Europe OTC Cold and Cough Medicines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Cold and Cough Medicines Market Facts & Figures by Country
3.6.1 Asia Pacific OTC Cold and Cough Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific OTC Cold and Cough Medicines Sales by Country (2019-2030)
3.6.3 Asia Pacific OTC Cold and Cough Medicines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America OTC Cold and Cough Medicines Market Facts & Figures by Country
3.7.1 Latin America OTC Cold and Cough Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America OTC Cold and Cough Medicines Sales by Country (2019-2030)
3.7.3 Latin America OTC Cold and Cough Medicines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Cold and Cough Medicines Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Cold and Cough Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa OTC Cold and Cough Medicines Sales by Country (2019-2030)
3.8.3 Middle East and Africa OTC Cold and Cough Medicines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Cold and Cough Medicines Sales by Type (2019-2030)
4.1.1 Global OTC Cold and Cough Medicines Sales by Type (2019-2024)
4.1.2 Global OTC Cold and Cough Medicines Sales by Type (2025-2030)
4.1.3 Global OTC Cold and Cough Medicines Sales Market Share by Type (2019-2030)
4.2 Global OTC Cold and Cough Medicines Revenue by Type (2019-2030)
4.2.1 Global OTC Cold and Cough Medicines Revenue by Type (2019-2024)
4.2.2 Global OTC Cold and Cough Medicines Revenue by Type (2025-2030)
4.2.3 Global OTC Cold and Cough Medicines Revenue Market Share by Type (2019-2030)
4.3 Global OTC Cold and Cough Medicines Price by Type (2019-2030)
5 Segment by Application
5.1 Global OTC Cold and Cough Medicines Sales by Application (2019-2030)
5.1.1 Global OTC Cold and Cough Medicines Sales by Application (2019-2024)
5.1.2 Global OTC Cold and Cough Medicines Sales by Application (2025-2030)
5.1.3 Global OTC Cold and Cough Medicines Sales Market Share by Application (2019-2030)
5.2 Global OTC Cold and Cough Medicines Revenue by Application (2019-2030)
5.2.1 Global OTC Cold and Cough Medicines Revenue by Application (2019-2024)
5.2.2 Global OTC Cold and Cough Medicines Revenue by Application (2025-2030)
5.2.3 Global OTC Cold and Cough Medicines Revenue Market Share by Application (2019-2030)
5.3 Global OTC Cold and Cough Medicines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Corporation Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi-Aventis OTC Cold and Cough Medicines Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson OTC Cold and Cough Medicines Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Reckitt Benckiser Group Plc.
6.3.1 Reckitt Benckiser Group Plc. Corporation Information
6.3.2 Reckitt Benckiser Group Plc. Description and Business Overview
6.3.3 Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Product Portfolio
6.3.5 Reckitt Benckiser Group Plc. Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG OTC Cold and Cough Medicines Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 GlaxoSmithKline Plc.
6.5.1 GlaxoSmithKline Plc. Corporation Information
6.5.2 GlaxoSmithKline Plc. Description and Business Overview
6.5.3 GlaxoSmithKline Plc. OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Plc. OTC Cold and Cough Medicines Product Portfolio
6.5.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.6 AstraZeneca Plc.
6.6.1 AstraZeneca Plc. Corporation Information
6.6.2 AstraZeneca Plc. Description and Business Overview
6.6.3 AstraZeneca Plc. OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca Plc. OTC Cold and Cough Medicines Product Portfolio
6.6.5 AstraZeneca Plc. Recent Developments/Updates
6.7 Pfizer Inc.
6.6.1 Pfizer Inc. Corporation Information
6.6.2 Pfizer Inc. Description and Business Overview
6.6.3 Pfizer Inc. OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Inc. OTC Cold and Cough Medicines Product Portfolio
6.7.5 Pfizer Inc. Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporation Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharmaceutical OTC Cold and Cough Medicines Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Prestige Brands Holdings, Inc.
6.9.1 Prestige Brands Holdings, Inc. Corporation Information
6.9.2 Prestige Brands Holdings, Inc. Description and Business Overview
6.9.3 Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Product Portfolio
6.9.5 Prestige Brands Holdings, Inc. Recent Developments/Updates
6.10 Procter & Gamble Co.
6.10.1 Procter & Gamble Co. Corporation Information
6.10.2 Procter & Gamble Co. Description and Business Overview
6.10.3 Procter & Gamble Co. OTC Cold and Cough Medicines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Procter & Gamble Co. OTC Cold and Cough Medicines Product Portfolio
6.10.5 Procter & Gamble Co. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Cold and Cough Medicines Industry Chain Analysis
7.2 OTC Cold and Cough Medicines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Cold and Cough Medicines Production Mode & Process
7.4 OTC Cold and Cough Medicines Sales and Marketing
7.4.1 OTC Cold and Cough Medicines Sales Channels
7.4.2 OTC Cold and Cough Medicines Distributors
7.5 OTC Cold and Cough Medicines Customers
8 OTC Cold and Cough Medicines Market Dynamics
8.1 OTC Cold and Cough Medicines Industry Trends
8.2 OTC Cold and Cough Medicines Market Drivers
8.3 OTC Cold and Cough Medicines Market Challenges
8.4 OTC Cold and Cough Medicines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global OTC Cold and Cough Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global OTC Cold and Cough Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global OTC Cold and Cough Medicines Market Competitive Situation by Manufacturers in 2023
Table 4. Global OTC Cold and Cough Medicines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global OTC Cold and Cough Medicines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global OTC Cold and Cough Medicines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global OTC Cold and Cough Medicines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market OTC Cold and Cough Medicines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of OTC Cold and Cough Medicines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of OTC Cold and Cough Medicines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of OTC Cold and Cough Medicines, Product Type & Application
Table 12. Global Key Manufacturers of OTC Cold and Cough Medicines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Cold and Cough Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Cold and Cough Medicines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OTC Cold and Cough Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global OTC Cold and Cough Medicines Sales by Region (2019-2024) & (K Units)
Table 18. Global OTC Cold and Cough Medicines Sales Market Share by Region (2019-2024)
Table 19. Global OTC Cold and Cough Medicines Sales by Region (2025-2030) & (K Units)
Table 20. Global OTC Cold and Cough Medicines Sales Market Share by Region (2025-2030)
Table 21. Global OTC Cold and Cough Medicines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global OTC Cold and Cough Medicines Revenue Market Share by Region (2019-2024)
Table 23. Global OTC Cold and Cough Medicines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global OTC Cold and Cough Medicines Revenue Market Share by Region (2025-2030)
Table 25. North America OTC Cold and Cough Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America OTC Cold and Cough Medicines Sales by Country (2019-2024) & (K Units)
Table 27. North America OTC Cold and Cough Medicines Sales by Country (2025-2030) & (K Units)
Table 28. North America OTC Cold and Cough Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America OTC Cold and Cough Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe OTC Cold and Cough Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe OTC Cold and Cough Medicines Sales by Country (2019-2024) & (K Units)
Table 32. Europe OTC Cold and Cough Medicines Sales by Country (2025-2030) & (K Units)
Table 33. Europe OTC Cold and Cough Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe OTC Cold and Cough Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific OTC Cold and Cough Medicines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific OTC Cold and Cough Medicines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific OTC Cold and Cough Medicines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific OTC Cold and Cough Medicines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific OTC Cold and Cough Medicines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America OTC Cold and Cough Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America OTC Cold and Cough Medicines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America OTC Cold and Cough Medicines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America OTC Cold and Cough Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America OTC Cold and Cough Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa OTC Cold and Cough Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa OTC Cold and Cough Medicines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa OTC Cold and Cough Medicines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa OTC Cold and Cough Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa OTC Cold and Cough Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global OTC Cold and Cough Medicines Sales (K Units) by Type (2019-2024)
Table 51. Global OTC Cold and Cough Medicines Sales (K Units) by Type (2025-2030)
Table 52. Global OTC Cold and Cough Medicines Sales Market Share by Type (2019-2024)
Table 53. Global OTC Cold and Cough Medicines Sales Market Share by Type (2025-2030)
Table 54. Global OTC Cold and Cough Medicines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global OTC Cold and Cough Medicines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global OTC Cold and Cough Medicines Revenue Market Share by Type (2019-2024)
Table 57. Global OTC Cold and Cough Medicines Revenue Market Share by Type (2025-2030)
Table 58. Global OTC Cold and Cough Medicines Price (US$/Unit) by Type (2019-2024)
Table 59. Global OTC Cold and Cough Medicines Price (US$/Unit) by Type (2025-2030)
Table 60. Global OTC Cold and Cough Medicines Sales (K Units) by Application (2019-2024)
Table 61. Global OTC Cold and Cough Medicines Sales (K Units) by Application (2025-2030)
Table 62. Global OTC Cold and Cough Medicines Sales Market Share by Application (2019-2024)
Table 63. Global OTC Cold and Cough Medicines Sales Market Share by Application (2025-2030)
Table 64. Global OTC Cold and Cough Medicines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global OTC Cold and Cough Medicines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global OTC Cold and Cough Medicines Revenue Market Share by Application (2019-2024)
Table 67. Global OTC Cold and Cough Medicines Revenue Market Share by Application (2025-2030)
Table 68. Global OTC Cold and Cough Medicines Price (US$/Unit) by Application (2019-2024)
Table 69. Global OTC Cold and Cough Medicines Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi-Aventis Corporation Information
Table 71. Sanofi-Aventis Description and Business Overview
Table 72. Sanofi-Aventis OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi-Aventis OTC Cold and Cough Medicines Product
Table 74. Sanofi-Aventis Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Johnson & Johnson OTC Cold and Cough Medicines Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Reckitt Benckiser Group Plc. Corporation Information
Table 81. Reckitt Benckiser Group Plc. Description and Business Overview
Table 82. Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Product
Table 84. Reckitt Benckiser Group Plc. Recent Developments/Updates
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Novartis AG OTC Cold and Cough Medicines Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. GlaxoSmithKline Plc. Corporation Information
Table 91. GlaxoSmithKline Plc. Description and Business Overview
Table 92. GlaxoSmithKline Plc. OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. GlaxoSmithKline Plc. OTC Cold and Cough Medicines Product
Table 94. GlaxoSmithKline Plc. Recent Developments/Updates
Table 95. AstraZeneca Plc. Corporation Information
Table 96. AstraZeneca Plc. Description and Business Overview
Table 97. AstraZeneca Plc. OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. AstraZeneca Plc. OTC Cold and Cough Medicines Product
Table 99. AstraZeneca Plc. Recent Developments/Updates
Table 100. Pfizer Inc. Corporation Information
Table 101. Pfizer Inc. Description and Business Overview
Table 102. Pfizer Inc. OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Pfizer Inc. OTC Cold and Cough Medicines Product
Table 104. Pfizer Inc. Recent Developments/Updates
Table 105. Sun Pharmaceutical Corporation Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sun Pharmaceutical OTC Cold and Cough Medicines Product
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Prestige Brands Holdings, Inc. Corporation Information
Table 111. Prestige Brands Holdings, Inc. Description and Business Overview
Table 112. Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Product
Table 114. Prestige Brands Holdings, Inc. Recent Developments/Updates
Table 115. Procter & Gamble Co. Corporation Information
Table 116. Procter & Gamble Co. Description and Business Overview
Table 117. Procter & Gamble Co. OTC Cold and Cough Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Procter & Gamble Co. OTC Cold and Cough Medicines Product
Table 119. Procter & Gamble Co. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. OTC Cold and Cough Medicines Distributors List
Table 123. OTC Cold and Cough Medicines Customers List
Table 124. OTC Cold and Cough Medicines Market Trends
Table 125. OTC Cold and Cough Medicines Market Drivers
Table 126. OTC Cold and Cough Medicines Market Challenges
Table 127. OTC Cold and Cough Medicines Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of OTC Cold and Cough Medicines
Figure 2. Global OTC Cold and Cough Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global OTC Cold and Cough Medicines Market Share by Type in 2023 & 2030
Figure 4. Pellets Product Picture
Figure 5. Drops Product Picture
Figure 6. Tablets Product Picture
Figure 7. Capsules Product Picture
Figure 8. Powders Product Picture
Figure 9. Sprays Product Picture
Figure 10. Global OTC Cold and Cough Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global OTC Cold and Cough Medicines Market Share by Application in 2023 & 2030
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Global OTC Cold and Cough Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global OTC Cold and Cough Medicines Market Size (2019-2030) & (US$ Million)
Figure 17. Global OTC Cold and Cough Medicines Sales (2019-2030) & (K Units)
Figure 18. Global OTC Cold and Cough Medicines Average Price (US$/Unit) & (2019-2030)
Figure 19. OTC Cold and Cough Medicines Report Years Considered
Figure 20. OTC Cold and Cough Medicines Sales Share by Manufacturers in 2023
Figure 21. Global OTC Cold and Cough Medicines Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest OTC Cold and Cough Medicines Players: Market Share by Revenue in 2023
Figure 23. OTC Cold and Cough Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global OTC Cold and Cough Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America OTC Cold and Cough Medicines Sales Market Share by Country (2019-2030)
Figure 26. North America OTC Cold and Cough Medicines Revenue Market Share by Country (2019-2030)
Figure 27. United States OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe OTC Cold and Cough Medicines Sales Market Share by Country (2019-2030)
Figure 30. Europe OTC Cold and Cough Medicines Revenue Market Share by Country (2019-2030)
Figure 31. Germany OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific OTC Cold and Cough Medicines Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific OTC Cold and Cough Medicines Revenue Market Share by Region (2019-2030)
Figure 38. China OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America OTC Cold and Cough Medicines Sales Market Share by Country (2019-2030)
Figure 48. Latin America OTC Cold and Cough Medicines Revenue Market Share by Country (2019-2030)
Figure 49. Mexico OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa OTC Cold and Cough Medicines Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa OTC Cold and Cough Medicines Revenue Market Share by Country (2019-2030)
Figure 54. Turkey OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE OTC Cold and Cough Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of OTC Cold and Cough Medicines by Type (2019-2030)
Figure 58. Global Revenue Market Share of OTC Cold and Cough Medicines by Type (2019-2030)
Figure 59. Global OTC Cold and Cough Medicines Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of OTC Cold and Cough Medicines by Application (2019-2030)
Figure 61. Global Revenue Market Share of OTC Cold and Cough Medicines by Application (2019-2030)
Figure 62. Global OTC Cold and Cough Medicines Price (US$/Unit) by Application (2019-2030)
Figure 63. OTC Cold and Cough Medicines Value Chain
Figure 64. OTC Cold and Cough Medicines Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
